Phytochemical Name : Deoxyrhapontigenin

Properties Information
PhytoCAT-ID PhytoCAT-710
Phytochemical name or plant extracts Deoxyrhapontigenin
PMID 27151591
Literature evidence Although current chemotherapeutic agents are active at the beginning of therapy, the most common risk is the development of resistance during later stages in almost all cancer types including breast cancer.
IUPAC name 5-[(E)-2-(4-methoxyphenyl)ethenyl]benzene-1,3-diol
Phytochemicals’ class or type of plant extracts Stilbenoid
Source of phytochemicals or plant Extracts Rheum undulatum
Geographical availability Buryatiya, China North-Central, China South-Central, Chita, Inner Mongolia, Irkutsk, Manchuria, Mongolia
Plant parts Root
Other cancers Breast cancer
Target gene or protein GRP78, IRE1α, eIF2α, CHOP, JNK, p38
Gene or Protein evidence Mechanistic investigations revealed that DR treatment causes endoplasmic reticulum (ER) dilation and upregulated the expression of ER stress markers GRP78, IRE1α, eIF2α, CHOP, JNK, and p38.
Target pathways ER stress-mediated apoptosis pathway
IC50 NA
Potency In summary, the present study suggests that the induction of ER stress-mediated apoptosis by DR may account for its cytotoxic effects in human breast cancer cells.
Cell line/ mice model MCF-7, MCF-7/adr
Additional information  Subsequently, we also identified that DR increases the levels of apoptotic fragment of PARP (89 kDa) in breast cancer cells. Blocking the expression of one of the components of the ER stress-mediated apoptosis pathway, CHOP using siRNA significantly decreased DR-induced apoptotic cleavage of PARP.
PubChem ID 6255462
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:696808-1
Safety NA